drugset / Trial / NCT06693765
A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants
Non-randomizedParallel-groupOpen-labelTreatment
Summary
A study to investigate the pharmacokinetics, safety, and tolerability of AZD4144 in participants with severe renal impairment, end-stage kidney disease, and in healthy participants.
Timeline
- Start
- 2024-11-18
- Primary completion
- 2025-04-23
- Completion
- 2025-04-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD4144 | Unknown | — | Oral |